A groundbreaking trial across 11 countries reveals a triple-action cancer jab can completely eradicate tumours in patients with advanced, treatment-resistant cancers.

Jab brought ‘unprecedentedly strong responses’ in patients whose disease had become resistant to chemotherapy and immunotherapy

A promising triple-action cancer jab being trialled at the Royal Marsden has shown encouraging results for some patients with head and neck cancer, with tumours disappearing…